Therapy failure and metastasis-associated mortality are stumbling blocks in the management of PDAC in patients. Failure of therapy is associated to intense hypoxic conditions of tumors. To develop effective therapies, a complete understanding of hypoxia-associated changes in genetic landscape of tumors during disease progression is needed. Because artificially immortalized cell lines do not rightly represent the disease progression, studying genetics of tumors in spontaneous models is warranted. In the current study, we generated a spectrum of spontaneous human (UM-PDC1; UM-PDC2)and murine (HI-PanL, HI-PancI, HI-PanM)models representing localized, invasive, and metastatic PDAC from a patient and transgenic mice (K-rasG12D/Pdxcre/Ink4a/p16-/). These spontaneous models grow vigorously under hypoxia and exhibit activated K-ras signaling, progressive loss of PTEN, and tumorigenicity in vivo. Whereas UM-PDC1 form localized tumors, the UM-PDC2 metastasize to lungs in mice. In an order of progression, these models exhibit genomic instability marked by gross chromosomal rearrangements, centrosome-number variations, Aurora-kinase/H2AX colocalization, loss of primary cilia, and α-tubulin acetylation. The RNA sequencing of hypoxic models followed by qRT-PCR validation and gene-set enrichment identified Intestine-Specific Homeobox factor (ISX)–driven molecular pathway as an indicator PDAC aggressivness. TCGA-PAAD clinical data analysis showed high ISX expression correlation to poor survival of PDAC patients, particularly women. The functional studies showed ISX as a regulator of i)invasiveness and migratory potential and ii)VEGF, MMP2, and NFκB activation in PDAC cells. We suggest that ISX is a potential druggable target and newly developed spontaneous cell models are valuable tools for studying mechanism and testing therapies for PDAC.
Bibliographical noteFunding Information:
This study was supported by an investigator award from American Institute of Cancer Research (AICR application # 09A074 ) to author (M.S.). The author (M.S.) is supported by US PHS grants ( CA193739 , CA184685 , and CA184685-02S1 ). We thank Dr. Anindya Bagchi and the genomic center of UoM for helping in RNA sequencing of models. We thank Lyn Oseath (Shared Resources, Masonic Cancer Center) for helping in karyotyping of cells models. We thank Neelofar Jan and Mudassir M. Banday for providing help in animal and qPCR validation studies, respectively.
© 2019 The Authors